Dr Reddy Long Dr Reddy can possibly give 8% in the coming days.. Good Movement seen in the last days and so there is a possibility of another 8%!!
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
64.00 INR
55.68 B INR
279.16 B INR
609.06 M
About DR. REDDY S LABORATORIES
Sector
CEO
Erez Israeli
Headquarters
Hyderabad
Website
Founded
1984
ISIN
INE089A01031
FIGI
BBG000CQND59
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
DR Reddy weekly and daily chart Strong breakout on both daily and weekly chart
Trend line breakout
Rising volume
Daily RSI >60
Weekly RSI >50
Looks Bullish
DR Reddy Laboratories Swing TradeHello,
Trend-Based Analysis. Buy the Dips, Sell The Rallies, Also Following the Trend. Let's see where the Price Action takes us, Riding the wave. Potential trade setups based on trend momentum.
Technical analysis based on trend identification and momentum, Looking for high-probability setups with
Dr. Reddy | Exited Short | Taken Long | BTSTAs I mentioned in my earlier post today, there was an inherent risk in shorting Dr. Reddy and that came true. Since the price was above the Daily Pivot, the bias was indeed bullish.
A long trade has now been initiated for a target to the above resistance zone. This would be a BTST type trade.
DR Reddy | Short | STBTThis price structure is similar to my earlier post about Bajaj Auto.
Clear rejection from the highs after a gap up opening.
Short position can be initiated for a target to 1230.
This however could be slightly more riskier than Bajaj Auto because the price is above the Monthly Pivot. So that risk el
Dr.Reddys - Pivot level - Potential for 1450Dr. Reddys has potential for the levels of 1450 , however the stock if breaks the levels of 1170 may slide to below levels before flying high.
Dr reddy 1W time frame Buy @ 1268 target @ 1408, 1419,1454 Dr reddy 1W time frame
Buy @ 1268 target @ 1408, 1419,1454
Risk reward 1:1
Ascending channel
Its just a view trade@ your own risk
Triple top chart weekly Triple top chart weekly suggests bearish reversal trend with neckline 1251
Entry Any high near to 1251
Target 1040
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DRREDDY is 1,376.90 INR — it has decreased by −0.08% in the past 24 hours. Watch DR. REDDY S LABORATORIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange DR. REDDY S LABORATORIES stocks are traded under the ticker DRREDDY.
DRREDDY stock has risen by 1.93% compared to the previous week, the month change is a 15.12% rise, over the last year DR. REDDY S LABORATORIES has showed a 18.09% increase.
We've gathered analysts' opinions on DR. REDDY S LABORATORIES future price: according to them, DRREDDY price has a max estimate of 1,655.00 INR and a min estimate of 1,070.00 INR. Watch DRREDDY chart and read a more detailed DR. REDDY S LABORATORIES stock forecast: see what analysts think of DR. REDDY S LABORATORIES and suggest that you do with its stocks.
DRREDDY reached its all-time high on Aug 21, 2024 with the price of 1,421.50 INR, and its all-time low was 7.20 INR and was reached on Dec 10, 1996. View more price dynamics on DRREDDY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DRREDDY stock is 1.45% volatile and has beta coefficient of 0.46. Track DR. REDDY S LABORATORIES stock price on the chart and check out the list of the most volatile stocks — is DR. REDDY S LABORATORIES there?
Today DR. REDDY S LABORATORIES has the market capitalization of 1.15 T, it has increased by 5.98% over the last week.
Yes, you can track DR. REDDY S LABORATORIES financials in yearly and quarterly reports right on TradingView.
DR. REDDY S LABORATORIES is going to release the next earnings report on Jan 23, 2025. Keep track of upcoming events with our Earnings Calendar.
DRREDDY earnings for the last quarter are 15.04 INR per share, whereas the estimation was 17.33 INR resulting in a −13.20% surprise. The estimated earnings for the next quarter are 18.17 INR per share. See more details about DR. REDDY S LABORATORIES earnings.
DR. REDDY S LABORATORIES revenue for the last quarter amounts to 80.16 B INR, despite the estimated figure of 77.09 B INR. In the next quarter, revenue is expected to reach 81.96 B INR.
DRREDDY net income for the last quarter is 12.55 B INR, while the quarter before that showed 13.92 B INR of net income which accounts for −9.82% change. Track more DR. REDDY S LABORATORIES financial stats to get the full picture.
Yes, DRREDDY dividends are paid annually. The last dividend per share was 40.00 INR. As of today, Dividend Yield (TTM)% is 0.58%. Tracking DR. REDDY S LABORATORIES dividends might help you take more informed decisions.
DR. REDDY S LABORATORIES dividend yield was 0.65% in 2023, and payout ratio reached 11.95%. The year before the numbers were 0.87% and 14.74% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 27.05 K employees. See our rating of the largest employees — is DR. REDDY S LABORATORIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. REDDY S LABORATORIES EBITDA is 81.00 B INR, and current EBITDA margin is 28.20%. See more stats in DR. REDDY S LABORATORIES financial statements.
Like other stocks, DRREDDY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. REDDY S LABORATORIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. REDDY S LABORATORIES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. REDDY S LABORATORIES stock shows the strong buy signal. See more of DR. REDDY S LABORATORIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.